Rapid Micro Biosystems (RPID) Shares Outstanding (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Shares Outstanding (Entity) of $41.3 million for Q1 2026, up 3.24% sequentially from $40.0 million in Q4 2025, and up 5.3% YoY from $39.2 million in Q1 2025.
Rapid Micro Biosystems (RPID) Shares Outstanding (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $41.3 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 5.3% year-over-year to $41.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $41.3 million (up 5.3% YoY) and the FY2025 annual result came in at $40.0 million, up 5.94% from the prior year.
- Shares Outstanding (Entity) rose to $41.3 million in Q1 2026 per RPID's latest filing, from $40.0 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $43.1 million in Q2 2023 and troughed at $36.4 million in Q1 2022.
- A 5-year average of $39.3 million and a median of $39.2 million in 2025 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) jumped 5573.64% in 2022, then fell 12.77% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $42.5 million in 2022, then declined by 12.61% to $37.1 million in 2023, then rose by 1.7% to $37.7 million in 2024, then increased by 5.94% to $40.0 million in 2025, then rose by 3.24% to $41.3 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $41.3 million, $40.0 million, and $39.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | 48.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 48.35 Mn |
| Mar 31, 2026 | 45.43 Mn |
| Dec 31, 2025 | 44.68 Mn |
| Sep 30, 2025 | 44.96 Mn |
| Jun 30, 2025 | 44.65 Mn |
| Mar 31, 2025 | 43.99 Mn |
| Dec 31, 2024 | 43.58 Mn |
| Sep 30, 2024 | 43.67 Mn |
| Jun 30, 2024 | 43.62 Mn |
| Mar 31, 2024 | 43.25 Mn |
| Dec 31, 2023 | 43.02 Mn |
| Sep 30, 2023 | 43.08 Mn |
| Jun 30, 2023 | 43.06 Mn |
| Mar 31, 2023 | 42.81 Mn |
| Dec 31, 2022 | 42.45 Mn |
| Sep 30, 2022 | 42.52 Mn |
| Jun 30, 2022 | 42.49 Mn |
| Mar 31, 2022 | 42.20 Mn |
| Dec 31, 2021 | 19.78 Mn |
| Sep 30, 2021 | 35.32 Mn |